Milligan Sandra
SEC insider (Form 3/4/5 filer). CIK 0001859810. Director at Gossamer Bio, Inc. (GOSS) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SAN DIEGO, CA.
Companies Milligan Sandra has filed insider reports for
- Gossamer Bio, Inc. (GOSS): Director
- Spyre Therapeutics, Inc. (SYRE): Director
- Aspira Women's Health Inc. (AWH): Officer, Interim CEO & President
Milligan Sandra
CIK: 0001859810
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 23, 2026GOSS
Gossamer Bio, Inc.
AwardDirectStock Option (Right to Buy)
10K shares- - Jun 4, 2026GOSS
Gossamer Bio, Inc.
AwardDirectStock Option (Right to Buy)
115K shares- - May 27, 2026SYRE
Spyre Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
8K shares- - Aug 19, 2025GOSS
Gossamer Bio, Inc.
PurchaseDirect26.1K shares at avg. $1.92$50K - Jun 25, 2025GOSS
Gossamer Bio, Inc.
AwardDirectStock Option (Right to Buy)
115K shares- - May 29, 2025SYRE
Spyre Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - Jan 8, 2025AWH
Aspira Women's Health Inc.
Tax PaymentDirect6.4K shares at avg. $0.70$4K - Dec 31, 2024AWH
Aspira Women's Health Inc.
ExerciseDirect20K shares- - Dec 31, 2024AWH
Aspira Women's Health Inc.
ExerciseDirectRestricted Stock Units
20K shares- - Nov 12, 2024AWH
Aspira Women's Health Inc.
AwardDirectStock option (right to buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  GOSS Gossamer Bio, Inc. | Award Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Jun 4, 2026 | GOSS Gossamer Bio, Inc. | Award Stock Option (Right to Buy) | 115,000 | - | - | Direct |
| May 27, 2026 |  SYRE Spyre Therapeutics, Inc. | Award Stock Option (Right to Buy) | 8,026 | - | - | Direct |
| Aug 19, 2025 | GOSS Gossamer Bio, Inc. | Purchase | 26,050 | $1.92 | $50,016 | Direct |
| Jun 25, 2025 | GOSS Gossamer Bio, Inc. | Award Stock Option (Right to Buy) | 115,000 | - | - | Direct |
| May 29, 2025 | SYRE Spyre Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 8, 2025 |  AWH Aspira Women's Health Inc. | Tax Payment | 6,356 | $0.70 | $4,449 | Direct |
| Dec 31, 2024 | AWH Aspira Women's Health Inc. | Exercise | 20,000 | - | $0 | Direct |
| Dec 31, 2024 | AWH Aspira Women's Health Inc. | Exercise Restricted Stock Units | 20,000 | - | - | Direct |
| Nov 12, 2024 | AWH Aspira Women's Health Inc. | Award Stock option (right to buy) | 25,000 | - | - | Direct |
1-10 of 11 transactions